Eagle Pharmaceuticals to Present at 31st Annual Piper Jaffray Healthcare Conference
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Nov 20, 2019--
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the 31 st Annual Piper Jaffray Healthcare Conference as follows:
Tuesday, December 3, 2019
11:30 a.m. Eastern Standard Time
Lotte New York Palace, New York, NY
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors + News Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing innovative and differentiated injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Additional information is available on the Company’s website at www.eagleus.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191120005269/en/
CONTACT: Investor Relations for Eagle Pharmaceuticals, Inc.:
Lisa M. Wilson
In-Site Communications, Inc.
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK NEW JERSEY
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Eagle Pharmaceuticals, Inc.
Copyright Business Wire 2019.
PUB: 11/20/2019 06:50 AM/DISC: 11/20/2019 06:50 AM